Recalls / Generics / Clindamycin Phosphate
Clindamycin Phosphate
5 FDA drug recalls involving generic “Clindamycin Phosphate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-11-26 | Class III | Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Tar | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2019-03-15 | Class III | Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by P | Pfizer Inc. |
| 2019-03-15 | Class III | Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Ph | Pfizer Inc. |
| 2019-03-15 | Class III | Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Ph | Pfizer Inc. |
| 2013-06-04 | Class II | Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 | Pharmacia & Upjohn LLC |